1. Home /
  2. Pharmaceuticals


Eli Lilly's Charts Look a Bit Frail

LLY is looking shaky, despite fundamental improvements from its weight-loss drug tirzepatide.

I'm Prescribing a New Approach Toward Eli Lilly as It Loses Upward Momentum

A couple bearish divergences indicate that the pace of the advance in the giant drugmaker's shares is slowing.

Bearish Bets: 3 Small-Cap Stocks You Should Consider Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

Can Johnson & Johnson Stock Keep Climbing?

A bearish divergence can sometimes foreshadow a correction.

Has Regeneron Pharmaceuticals Run Too Far?

Traders have one of two choices to make here.

Just a Spoonful of Profits to Help the Merck Go Down

Here's where I think MRK can go and how to play it.

With This Pharma Value Play, the Market's Punishment Doesn't Fit the Crime

The growth crowd has moved on, leaving a stock trading at attractive levels.

Jazz Pharmaceuticals Is Not Playing My Song

Weakness in the broad market averages is likely to negatively impact the shares.

7 Best Buys in Biotech and Drug Development

Recently poor sector performance is creating opportunity for long-term investors.

We Have a New AbbVie Price Target After Our Previous One Was Reached

Here's our fresh take on the shares.